Teladoc Health to Announce First Quarter 2019 Financial Results

Go back to Teladoc Health to Announce First Quarter 2019 Financial Results

Oppenheimer Reiterates Outperform Rating on Teladoc (TDOC)

April 10, 2019 8:57 AM EDT

Oppenheimer analyst Mohan Naidu reiterated an Outperform rating and $84.00 price target on Teladoc (NYSE: TDOC) as CMS finalized the guidelines for Telehealth services for Medicare Advantage member. The guidelines significantly expand TDOCs market opportunity. Starting 2020, MA enrollees can access and receive Telehealth benefits from... More